세계의 바클로펜 시장 규모 : 유형별, 용도별, 지역 범위별, 예측

Baclofen Market Size And Forecast

Baclofen Market size is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2026 to 2032.

The Global Baclofen Market is being driven by rising awareness regarding spasms and accompanying pain, clonus, and muscular rigidity treatment in the health care industry. Furthermore, government funding in muscle stiffness research is accelerating the target market's growth. Furthermore, the increasing use of Baclofen in Intrathecal pumps, which carry the drug straight to the spinal fluid rather than passing through the digestive and circulatory systems first, is boosting the market's growth. The Global Baclofen Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Baclofen Market Definition

Baclofen is a crystalline powder that is white to off-white in color and has a molecular weight of 213.66 g/mol. Its chemical name is 4-amino-3-(4-chlorophenyl) butanoic acid. It's used to treat the symptoms of multiple sclerosis spasticity, particularly spasms and associated pain, clonus, and muscular rigidity. It can be used alone or in combination with other drugs. Baclofen is available in tablet, suspension, and topical cream base forms. Water is moderately soluble, methanol is somewhat soluble, and chloroform is insoluble. Baclofen works by activating the GABAB receptor, which is similar to phenibut, another medicine that activates this receptor and has some of the same effects.

Hiccups and muscle spasms near the end of life can also be treated with Baclofen. It is administered either orally or directly into the spinal canal. In the treatment of muscle spasticity, it acts as a GABA agonist that is selective for GABA-B receptors. It's marketed as Lioresel, and it's also found in topical cream formulations for pain control. It comes in pill, suspension, and topical cream base forms. Baclofen is available in hospital pharmacies, retail pharmacies, and online pharmacies. Baclofen has also been used to treat alcohol-related disorders, but according to a comprehensive review published in 2018, the evidence for its usage as a first-line medication is still equivocal.

Drowsiness, dizziness, weakness, exhaustion, headache, difficulty sleeping, nausea, and vomiting are some of the side effects of Baclofen. Baclofen is taken orally as a pill or a liquid. Baclofen is used to treat symptomatic cerebral spasticity in children aged 0 to 18, particularly in cases of infantile cerebral palsy, as well as after cerebrovascular events and in the setting of neoplastic or degenerative brain illness. Bioequivalence exists between these two formulations.

The liquid may be especially beneficial for youngsters or individuals who cannot consume tablets. With the liquid, dosage titration may be regulated more precisely. The lowest dose possible while yet achieving an optimal response is suggested. Before commencing baclofen treatment, it's a good idea to analyze the patient's overall clinical progress realistically. It is critical to carefully titrate the dosage (especially in the elderly) until the illness is stabilized. Side effects may develop if a high dose is started or if the dose is raised too quickly.

Global Baclofen Market Overview

The growing usage of Baclofen for the treatment of spastic movement disorders, particularly in cases of spinal cord injury, cerebral palsy, and multiple sclerosis has fueled the Baclofen Market's prospective growth. The market is predicted to increase as the government invests more in muscular stiffness research in the health care industry. Furthermore, baclofen is widely used to treat a variety of nervous system problems, which has fueled the market expansion. Baclofen inhibits both monosynaptic and polysynaptic reflexes at the spinal level, probably by afferent terminal hyperpolarization.

As a result, the Global Baclofen Market's growth curve is being supported. Baclofen is increasingly being used in Intrathecal pumps, which carry the medication straight to the spinal fluid rather than passing through the digestive and circulatory systems first, boosting the market's growth. Baclofen has lately been examined for the treatment of alcohol withdrawal, but no conclusions have been reached about its efficacy in this situation. The EPA granted baclofen marketing authorization for use in alcoholism therapy in 2018, but only if all other therapies had failed.

Furthermore, the expanding acceptance of Baclofen for the treatment of various nervous system illnesses, as well as increased government expenditure in the health care industry, are likely to provide profitable prospects for the market in the future years. However, Baclofen's side effects, such as weakness, exhaustion, headache, difficulty sleeping, nausea and vomiting, urine retention, or constipation, are predicted to limit market expansion. Vomiting, general weakness, drowsiness, respiratory insufficiency, seizures, atypical pupil size, dizziness, headaches, hypertension, hyporeflexia, coma, and death are all signs of a Baclofen overdose. In the approaching years, this aspect is also predicted to limit the Baclofen Market.

Global Baclofen Market: Segmentation Analysis

The Global Baclofen Market is segmented on the basis of Type, Application, And Geography.

Baclofen Market, By Type

• Tablet 10mg
• Tablet 20mg

Based on Type, The market is bifurcated into Tablet 10mg and Tablet 20mg. The market is dominated by the Tablet 10mg segment. This is owing to baclofen's standard dosage of 100 mg per day for adults and 60 mg per day for children aged 8 and up, for whom a 20 mg pill is most commonly used. Symptom control is usually satisfactory with doses up to 60 mg per day, although careful modification is often required to fit the needs of each sufferer.

• If necessary, the amount can be gradually raised, although a daily maximum dose of more than 100 mg is not recommended unless the individual is hospitalized and under close medical supervision. In some circumstances, smaller, more frequent doses may be preferable over larger, more spaced ones. Several individuals may also benefit from using baclofen solely at night to relieve severe flexor spasms. A single dose taken about an hour before performing specified tasks such as showering, dressing, shaving, or physiotherapy can also help with mobility.

Baclofen Market, By Application

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharma

Based on Application, The market is bifurcated into Hospital Pharmacy, Retail Pharmacy, and Online Pharma. The Retail Pharmacy segment has the biggest market share among the following segments. This is because if you have a doctor's prescription, you can buy baclofen at any local drugstore to deal with emergency medical circumstances.

Baclofen Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Geography, The Global Baclofen Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The major market is dominated by the North American division. This is attributable to the aging population, the existence of top manufacturers, the growing population, cutting-edge technology, and innovations. Due to increased Baclofen production in Europe, the Baclofen market share in Europe is likely to grow significantly in the future years. Because raw materials are readily available in North America, the region is expected to grow rapidly. Due to the increasing growth of the economic estate sector in the Asia Pacific, the market is expected to grow at a reasonable rate.

Key Players

The "Global Baclofen Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are LGM Pharma, Lannett, Beijing 4A Biotech, Novartis Pharma Schweiz, North Star Rx, Par Pharmaceuticals, Qualitest Products, Teva Pharmaceuticals. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL BACLOFEN MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL BACLOFEN MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL BACLOFEN MARKET, BY TYPE

• 5.1 Overview
• 5.2 Tablet10mg
• 5.3 Tablet 20mg

6 GLOBAL BACLOFEN MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Hospital Pharmacy
• 6.3 Retail Pharmacy
• 6.4 Online Pharma

7 GLOBAL BACLOFEN MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East and Africa

8 GLOBAL BACLOFEN MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 LGM Pharma
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Lannett
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Beijing 4A Biotech
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Novartis Pharma Schweiz
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 North Star Rx
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Par Pharmaceuticals
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Qualitest Products
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Teva Pharmaceuticals
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research